Clovis Oncology News
Most Popular Clovis Oncology Story
UPDATED: Celgene snaps up Avila Therapeutics in $925M buyout
In less than five years Avila Therapeutics nailed down a reputation as an exciting developer of covalent drugs, with a lead Btk inhibitor for cancer garnering attention at a very early stage of Read more...
Latest Headlines
- January 26, 2012
- January 20, 2012
- January 17, 2012
- November 16, 2011
- November 15, 2011
- November 11, 2010
- May 25, 2010
- February 24, 2010
- November 24, 2009
- July 29, 2009
- June 29, 2009
- June 29, 2009
- June 8, 2009
- May 21, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
